{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:52:45Z","timestamp":1777614765553,"version":"3.51.4"},"reference-count":34,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1620\/tjem.239.251","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T22:08:49Z","timestamp":1468966129000},"page":"251-261","source":"Crossref","is-referenced-by-count":20,"title":["Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice"],"prefix":"10.1620","volume":"239","author":[{"given":"Xiang","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, The First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weicheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaqin","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, GaoChun People\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lele","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxin","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Nanjing University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Antoniades, H.N., Bravo, M.A., Avila, R.E., Galanopoulos, T., Neville-Golden, J., Maxwell, M. &amp; Selman, M. (1990) Platelet-derived growth factor in idiopathic pulmonary fibrosis. <i>J. Clin. Invest.<\/i>, 86, 1055-1064.","DOI":"10.1172\/JCI114808"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Camelo, A., Dunmore, R., Sleeman, M.A. &amp; Clarke, D.L. (2014) The epithelium in idiopathic pulmonary fibrosis: breaking the barrier. <i>Front. Pharmacol.<\/i>, 4, 173.","DOI":"10.3389\/fphar.2013.00173"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Chakraborty, S., Chopra, P., Ambi, S.V., Dastidar, S.G. &amp; Ray, A. (2014) Emerging therapeutic interventions for idiopathic pulmonary fibrosis. <i>Expert Opin. Investig. Drugs<\/i>, 23, 893-910.","DOI":"10.1517\/13543784.2014.913569"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chen, Y.L., Lv, J., Ye, X.L., Sun, M.Y., Xu, Q., Liu, C.H., Min, L.H., Li, H.P., Liu, P. &amp; Ding, X. (2011) Sorafenib inhibits transforming growth factor <i>\u03b2<\/i>1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes. <i>Hepatology<\/i>, 53, 1708-1718.","DOI":"10.1002\/hep.24254"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chen, Y.L., Zhang, X., Bai, J., Gai, L., Ye, X.L., Zhang, L., Xu, Q., Zhang, Y.X., Xu, L., Li, H.P. &amp; Ding, X. (2013) Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation. <i>Cell Death Dis.<\/i>, 4, e665.","DOI":"10.1038\/cddis.2013.154"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cottin, V. (2016) Idiopathic interstitial pneumonias with connective tissue diseases features: A review. <i>Respirology<\/i>, 21, 245-258.","DOI":"10.1111\/resp.12588"},{"key":"7","doi-asserted-by":"crossref","unstructured":"de Wit, D., Guchelaar, H.J., den Hartigh, J., Gelderblom, H. &amp; van Erp, N.P. (2015) Individualized dosing of tyrosine kinase inhibitors: are we there yet? <i>Drug Discov. Today<\/i>, 20, 18-36.","DOI":"10.1016\/j.drudis.2014.09.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Desai, P., Yang, J., Tian, B., Sun, H., Kalita, M., Ju, H., Paulucci-Holthauzen, A., Zhao, Y., Brasier, A.R. &amp; Sadygov, R.G. (2015) Mixed-effects model of epithelial-mesenchymal transition reveals rewiring of signaling networks. <i>Cell. Signal.<\/i>, 27, 1413-1425.","DOI":"10.1016\/j.cellsig.2015.03.024"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Eberlein, C., Rooney, C., Ross, S.J., Farren, M., Weir, H.M. &amp; Barry, S.T. (2015) E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin <i>\u03b1<\/i>v<i>\u03b2<\/i>6 and maintained through TGF<i>\u03b2<\/i> signalling. <i>Oncogene<\/i>, 34, 704-716.","DOI":"10.1038\/onc.2013.600"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Faivre, S., Delbaldo, C., Vera, K., Robert, C., Lozahic, S., Lassau, N., Bello, C., Deprimo, S., Brega, N., Massimini, G., Armand, J.P., Scigalla, P. &amp; Raymond, E. (2006) Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. <i>J. Clin. Oncol.<\/i>, 24, 25-35.","DOI":"10.1200\/JCO.2005.02.2194"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Fierro-Fernandez, M., Busnadiego, O., Sandoval, P., Espinosa-Diez, C., Blanco-Ruiz, E., Rodriguez, M., Pian, H., Ramos, R., Lopez-Cabrera, M., Garcia-Bermejo, M.L. &amp; Lamas, S. (2015) miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2. <i>EMBO Rep.<\/i>, 16, 1358-1377.","DOI":"10.15252\/embr.201540750"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Fukunaga, S., Kakehashi, A., Sumida, K., Kushida, M., Asano, H., Gi, M. &amp; Wanibuchi, H. (2015) Integrative analyses of miRNA and proteomics identify potential biological pathways associated with onset of pulmonary fibrosis in the bleomycin rat model. <i>Toxicol. Appl. Pharmacol.<\/i>, 286, 188-197.","DOI":"10.1016\/j.taap.2015.04.014"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hiwatari, N., Shimura, S., Yamauchi, K., Nara, M., Hida, W. &amp; Shirato, K. (1997) Significance of elevated procollagen-III-peptide and transforming growth factor-beta levels of bronchoalveolar lavage fluids from idiopathic pulmonary fibrosis patients. <i>Tohoku J. Exp. Med.<\/i>, 181, 285-295.","DOI":"10.1620\/tjem.181.285"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Imbulgoda, A., Heng, D.Y. &amp; Kollmannsberger, C. (2014) Sunitinib in the treatment of advanced solid tumors. <i>Recent Results Cancer Res.<\/i>, 201, 165-184.","DOI":"10.1007\/978-3-642-54490-3_9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Jamall, I.S., Finelli, V.N. &amp; Que Hee, S.S. (1981) A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. <i>Anal. Biochem.<\/i>, 112, 70-75.","DOI":"10.1016\/0003-2697(81)90261-X"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kim, H.J., Perlman, D. &amp; Tomic, R. (2015) Natural history of idiopathic pulmonary fibrosis. <i>Respir. Med.<\/i>, 109, 661-670.","DOI":"10.1016\/j.rmed.2015.02.002"},{"key":"17","unstructured":"Kim, S., Ding, W., Zhang, L., Tian, W. &amp; Chen, S. (2014) Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials. <i>Onco Targets Ther.<\/i>, 7, 719-728."},{"key":"18","doi-asserted-by":"crossref","unstructured":"King, T.E. Jr., Bradford, W.Z., Castro-Bernardini, S., Fagan, E.A., Glaspole, I., Glassberg, M.K., Gorina, E., Hopkins, P.M., Kardatzke, D., Lancaster, L., Lederer, D.J., Nathan, S.D., Pereira, C.A., Sahn, S.A., Sussman, R., et al. (2014) A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. <i>N. Engl. J. Med.<\/i>, 370, 2083-2092.","DOI":"10.1056\/NEJMoa1402582"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Kojonazarov, B., Sydykov, A., Pullamsetti, S.S., Luitel, H., Dahal, B.K., Kosanovic, D., Tian, X., Majewski, M., Baumann, C., Evans, S., Phillips, P., Fairman, D., Davie, N., Wayman, C., Kilty, I., et al. (2013) Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling. <i>Int. J. Cardiol.<\/i>, 167, 2630-2637.","DOI":"10.1016\/j.ijcard.2012.06.129"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Kong, D., Zhang, F., Shao, J., Wu, L., Zhang, X., Chen, L., Lu, Y. &amp; Zheng, S. (2015) Curcumin inhibits cobalt chloride-induced epithelial-to-mesenchymal transition associated with interference with TGF-<i>\u03b2<\/i>\/Smad signaling in hepatocytes. <i>Lab. Invest.<\/i>, 95, 1234-1245.","DOI":"10.1038\/labinvest.2015.107"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Majumder, S., Piguet, A.C., Dufour, J.F. &amp; Chatterjee, S. (2013) Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis. <i>Eur. J. Pharmacol.<\/i>, 705, 86-95.","DOI":"10.1016\/j.ejphar.2013.02.026"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Nanthakumar, C.B., Hatley, R.J., Lemma, S., Gauldie, J., Marshall, R.P. &amp; Macdonald, S.J. (2015) Dissecting fibrosis: therapeutic insights from the small-molecule toolbox. <i>Nat. Rev. Drug Discov.<\/i>, 14, 693-720.","DOI":"10.1038\/nrd4592"},{"key":"23","doi-asserted-by":"crossref","unstructured":"O\u2019Beirne, S.L., Walsh, S.M., Fabre, A., Reviriego, C., Worrell, J.C., Counihan, I.P., Lumsden, R.V., Cramton-Barnes, J., Belperio, J.A., Donnelly, S.C., Boylan, D., Marchal-Somme, J., Kane, R. &amp; Keane, M.P. (2015) CXCL9 Regulates TGF-<i>\u03b2<\/i>1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells. <i>J. Immunol.<\/i>, 195, 2788-2796.","DOI":"10.4049\/jimmunol.1402008"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Oechsle, K., Honecker, F., Cheng, T., Mayer, F., Czaykowski, P., Winquist, E., Wood, L., Fenner, M., Glaesener, S., Hartmann, J.T., Chi, K., Bokemeyer, C. &amp; Kollmannsberger, C. (2011) Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group\/German Testicular Cancer Study Group cooperative study. <i>Ann. Oncol.<\/i>, 22, 2654-2660.","DOI":"10.1093\/annonc\/mdr026"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Okumura, N., Minamiyama, R., Ho, L.T., Kay, E.P., Kawasaki, S., Tourtas, T., Schlotzer-Schrehardt, U., Kruse, F.E., Young, R.D., Quantock, A.J., Kinoshita, S. &amp; Koizumi, N. (2015) Involvement of ZEB1 and Snail1 in excessive production of extracellular matrix in Fuchs endothelial corneal dystrophy. <i>Lab. Invest.<\/i>, 95, 1291-1304.","DOI":"10.1038\/labinvest.2015.111"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Richeldi, L., du Bois, R.M., Raghu, G., Azuma, A., Brown, K.K., Costabel, U., Cottin, V., Flaherty, K.R., Hansell, D.M., Inoue, Y., Kim, D.S., Kolb, M., Nicholson, A.G., Noble, P.W., Selman, M., et al. (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. <i>N. Engl. J. Med.<\/i>, 370, 2071-2082.","DOI":"10.1056\/NEJMoa1402584"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Roskoski, R. Jr. (2007) Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. <i>Biochem. Biophys. Res. Commun.<\/i>, 356, 323-328.","DOI":"10.1016\/j.bbrc.2007.02.156"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Spagnolo, P., Maher, T.M. &amp; Richeldi, L. (2015) Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy. <i>Pharmacol. Ther.<\/i>, 152, 18-27.","DOI":"10.1016\/j.pharmthera.2015.04.005"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Staitieh, B.S., Renzoni, E.A. &amp; Veeraraghavan, S. (2015) Pharmacologic therapies for idiopathic pulmonary fibrosis, past and future. <i>Ann. Med.<\/i>, 47, 100-105.","DOI":"10.3109\/07853890.2014.991751"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Tian, B., Li, X., Kalita, M., Widen, S.G., Yang, J., Bhavnani, S.K., Dang, B., Kudlicki, A., Sinha, M., Kong, F., Wood, T.G., Luxon, B.A. &amp; Brasier, A.R. (2015) Analysis of the TGF<i>\u03b2<\/i>-induced program in primary airway epithelial cells shows essential role of NF-<i>\u03ba<\/i>B\/RelA signaling network in type II epithelial mesenchymal transition. <i>BMC Genomics<\/i>, 16, 529.","DOI":"10.1186\/s12864-015-1707-x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Wen, J., Li, H.Z., Ji, Z.G. &amp; Jin, J. (2015) Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro. <i>Cancer Cell Int.<\/i>, 15, 26.","DOI":"10.1186\/s12935-015-0179-z"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Wollin, L., Wex, E., Pautsch, A., Schnapp, G., Hostettler, K.E., Stowasser, S. &amp; Kolb, M. (2015) Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis. <i>Eur. Respir. J.<\/i>, 45, 1434-1445.","DOI":"10.1183\/09031936.00174914"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Yang, J., Velikoff, M., Canalis, E., Horowitz, J.C. &amp; Kim, K.K. (2014) Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor. <i>Am. J. Physiol. Lung Cell. Mol. Physiol.<\/i>, 306, L786-796.","DOI":"10.1152\/ajplung.00243.2013"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Zerr, P., Palumbo-Zerr, K., Huang, J., Tomcik, M., Sumova, B., Distler, O., Schett, G. &amp; Distler, J.H. (2016) Sirt1 regulates canonical TGF-<i>\u03b2<\/i> signalling to control fibroblast activation and tissue fibrosis. <i>Ann. Rheum. Dis.<\/i>, 75, 226-233.","DOI":"10.1136\/annrheumdis-2014-205740"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/239\/4\/239_251\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:45:34Z","timestamp":1498329934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/239\/4\/239_251\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.239.251","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}